Caplin Point Laboratories reports 23% rise in Q1 consolidated net profit

07 Aug 2025 Evaluate

Caplin Point Laboratories has reported result for first quarter ended June 30, 2025 (Q1FY26).

The company has reported 18.40% rise in its net profit at Rs 85.89 crore for the quarter ended June 30, 2025 as compared to Rs 72.54 crore for the same quarter in the previous year. The total income of the company increased by 3.60% at Rs 214.60 crore for Q1FY26 as compared to Rs 207.14 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 23.26% rise in its net profit at Rs 152.80 crore for Q1FY26 as compared to Rs 123.97 crore for the same quarter in the previous year. The total income of the company increased by 11.69% at Rs 533.36 crore for Q1FY26 as compared to Rs 477.52 crore for the corresponding quarter previous year.

Caplin Point Lab Share Price

1963.05 -13.80 (-0.70%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×